IRS1 and gestational diabetes: Moreover, in late gestation, the ability of insulin to suppress lipolysis in adipose tissue is reduced resulting in increased release of non-esterified fatty acids (NEFAs) in maternal circulation and subsequently higher carnitine consumption [19], a phenomenon enhanced in GDM probably due to decreased insulin receptor substrate-1 (IRS-1) levels [20,21].